(Q45410872)

English

Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs

scientific article published on 10 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Babesia gibsoni

object named as

Babesia gibsoni

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

7

object named as

Ikuo Igarashi

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

9

object named as

Xuenan Xuan

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Shinya Fukumoto

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Yoh Tamaki

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Masashi Okamura

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Natsuko Yokoyama

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Tomoko Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hiroshi Suzuki

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

10 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1334-1341

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Canine piroplasmosis due to Babesia gibsoni: clinical and morphological aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Babesia gibsoni Infection in a Dog from Indiana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Babesia gibsoni infection among dogs in the southeastern United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Immunosuppression in dogs naturally infected with Babesia gibsoni

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Clinical and hematologic effects of experimental infection of dogs with recently identified Babesia gibsoni-like isolates from Oklahoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Fatal Babesia gibsoni infection in a dog from Spain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Designing blood-stage vaccines against Babesia bovis and B. bigemina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

T cells as mediators of protective immunity against liver stages of Plasmodium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

A multilateral effort to develop DNA vaccines against falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Prospects for a human Toxoplasma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Morphological changes of Babesia gibsoni grown in canine red blood cell-substituted severe combined immune deficiency mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Serodiagnosis of canine Babesia gibsoni infection by enzyme-linked immunosorbent assay with recombinant P50 expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.083

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.09.083

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45410872&oldid=2076835955"